Results 181 to 190 of about 807,900 (313)
Beyond discretization: why cognitive science should embrace continuity. [PDF]
Di Pietro I, Viviani G.
europepmc +1 more source
From Something Old to Something New: Functionalist Lessons for the Cognitive Science of Scientific Creativity. [PDF]
Sanches de Oliveira G.
europepmc +1 more source
ABSTRACT Objective Isolated rapid eye movement sleep behavior disorder (iRBD) is a prodromal state for Lewy body disorders and exhibits biological heterogeneity that may influence clinical expression and progression. We examined clinical features in individuals with iRBD and biomarker‐defined synucleinopathy.
Daniel Weintraub +24 more
wiley +1 more source
The cognitive science of COVID-19: Acceptance, denial, and belief change. [PDF]
Thagard P.
europepmc +1 more source
Early Clinical, Imaging, and Pathological Characteristics of SRPK3/TTN‐Digenic Myopathy
ABSTRACT Objective SRPK3/TTN‐digenic myopathy was recently established as a skeletal muscle myopathy caused by digenic inheritance. This study characterizes the early clinical presentation of SRPK3/TTN‐digenic myopathy in one previously reported and seven newly identified pediatric patients.
Rotem Orbach +23 more
wiley +1 more source
AI-driven complex systems redefine cognitive science. [PDF]
Wang P, Sun X, Zou L, Law EL, Paas F.
europepmc +1 more source
Toward Cumulative Cognitive Science: A Comparison of Meta-Analysis, Mega-Analysis, and Hybrid Approaches. [PDF]
Koile E, Cristia A.
europepmc +1 more source
Foundations of Cognitive Science [PDF]
openaire +2 more sources
A spreading-activation model of the semantic coordination of speech and gesture
Kopp S, Bergmann K, Kahl S. A spreading-activation model of the semantic coordination of speech and gesture. In: Proceedings of the 35th Annual Meeting of the Cognitive Science Society (CogSci 2013). Austin, TX: Cognitive Science Society; 2013: 823-828.
Kopp, Stefan ; https://orcid.org/ +2 more
core
Movement Disorders in Aicardi–Goutières Syndrome and Response to Immunomodulation
ABSTRACT This study characterizes movement disorders and treatment responses in seven children with Aicardi–Goutières syndrome (AGS). We retrospectively evaluated motor phenotypes, neuroimaging, and interferon signatures in patients treated with baricitinib or anifrolumab. Spasticity affected all patients, while dystonia was present in 4/7.
Enrique Gonzalez Saez‐Diez +10 more
wiley +1 more source

